NCT07409558 3D Digital Assessment of Soft Tissue Changes After Modified FGG
| NCT ID | NCT07409558 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kahramanmaras Sutcu Imam University |
| Condition | Gingival Recession, Localized |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2025-01-04 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2025-01-04 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this randomized controlled clinical trial is to evaluate the effects of conventional free gingival graft (FGG) and modified free gingival graft (ModFGG) techniques on soft tissue thickness, volumetric change, and creeping attachment in mandibular incisors using three-dimensional direct digital analysis. The study will include a total of 34 systemically healthy, non-smoking individuals with localized Cairo Class II gingival recession. Participants will be randomly assigned to the FGG (control) and ModFGG (test) groups. Clinical measurements will be performed before surgery and at 1, 3, and 6 months post-surgery. Soft tissue thickness and volumetric changes will be analyzed three-dimensionally by overlaying digital models obtained with an intraoral scanner. Gingival recession depth, keratinized tissue height, and creeping attachment will also be assessed. The aim is to provide clinical evidence regarding the effects of the modified free gingival graft technique on soft tissue stability and volumetric gains.
Eligibility Criteria
Inclusion Criteria: * Age 18 years or older * Systemically healthy individuals * Non-smokers * Presence of localized Cairo Class II gingival recession with a vertical recession depth of ≥3 mm on the buccal surfaces of mandibular incisors * Probing pocket depth of ≤3 mm at the tooth/teeth to be treated * No tooth mobility (mobility grade ≤1) * Absence of cervical composite restorations or non-carious cervical lesions * Presence of a shallow vestibule (\<5 mm) Exclusion Criteria: * Pregnancy or lactation * Untreated periodontal disease * Presence of parafunctional habits * Poor oral hygiene, defined as a full-mouth plaque score \>20% * Malpositioned, rotated, or crowded teeth in the buccal position * Known systemic diseases (e.g., acquired immunodeficiency syndrome, diabetes mellitus) * Any condition or medication that may affect gingival wound healing * ASA physical status classification III or higher
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07409558 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Gingival Recession, Localized. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07409558 currently recruiting?
Yes, NCT07409558 is actively recruiting participants. Contact the research team at dtesrabozkurt@gmail.com for enrollment information.
Where is the NCT07409558 trial being conducted?
This trial is being conducted at Kahramanmaraş, Turkey (Türkiye).
Who is sponsoring the NCT07409558 clinical trial?
NCT07409558 is sponsored by Kahramanmaras Sutcu Imam University. The trial plans to enroll 34 participants.